Every company
licensed to make
a drug in America.
A register of 8,865 pharmaceutical companies and 9,828 inspected facilities across 81 countries. Who makes what, where it is made, what is running short, and what comes off patent next. Free, and nobody can pay to change a fact in it.
By capability
Contract Manufacturers (CDMO)
3,143Firms registered with the FDA to manufacture finished drug product. The core of the $275bn pharmaceutical outsourcing market.
API Manufacturers
1,751Active pharmaceutical ingredient producers, including the Indian and Chinese plants that supply most US generics and rarely appear in Western directories.
Testing Laboratories
2,061Establishments registered for analysis: release testing, stability, method development and quality control.
Packaging & Repackaging
1,300Primary and secondary packaging, kitting, serialisation and repackaging operations.
Labelling Services
1,399Establishments registered for labelling and relabelling of drug product.
Largest by registered footprint
Ranked on FDA-registered manufacturing sites, so scale here is measured rather than claimed. A company cannot buy a higher position.
In shortage now
1,174 activeWhere drugs are actually made
Any site supplying the US market must register with the FDA wherever it sits, which makes this close to a global census of manufacturing capacity.
Your profile is already here.
Claim it and take the enquiries.
Every registered establishment already has a page built from its FDA record. Claiming it lets you add the things the federal record cannot show: capacity, equipment, certifications and a route for buyers to reach you.
Compiled from the FDA Drug Establishments Current Registration Site (DECRS), the openFDA National Drug Code Directory, the FDA Orange Book and the FDA drug shortage database. All are public federal records. Registration indicates a site is authorised for an operation; it is not a quality judgement and not a substitute for your own audit. This site is independent of the FDA. Full methodology.